The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
124647643 12464764 3 F 20160322 20160817 20160614 20160828 EXP GB-TEVA-667033ACC TEVA 75.00 YR M Y 99.00000 KG 20160829 MD GB GB

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
124647643 12464764 1 PS PREDNISOLONE. PREDNISOLONE 1 Oral U U 89081 130 MG
124647643 12464764 2 SS MELPHALAN MELPHALAN 1 Oral U U 0 20 MG
124647643 12464764 3 SS VELCADE BORTEZOMIB 1 Subcutaneous U 1537302,V15541-09,1537301 0 2.75 MG
124647643 12464764 4 C ACICLOVIR ACYCLOVIR 1 Oral 800 MILLIGRAM DAILY; 3200 MG 0 200 MG TABLET QID
124647643 12464764 5 C ALLOPURINOL. ALLOPURINOL 1 Oral 300 MILLIGRAM DAILY; 1200 MG 0 300 MG TABLET QD
124647643 12464764 6 C ATORVASTATIN ATORVASTATIN 1 Oral 5 MILLIGRAM DAILY; 0 5 MG TABLET QD
124647643 12464764 7 C COCODAMOL ACETAMINOPHENCODEINE PHOSPHATE 1 Oral 0 2 DF TABLET
124647643 12464764 8 C DOXAZOSIN DOXAZOSINDOXAZOSIN MESYLATE 1 Oral 4 MILLIGRAM DAILY; 0 4 MG TABLET QD
124647643 12464764 9 C LOPERAMIDE LOPERAMIDE 1 Oral 0 2 MG CAPSULE
124647643 12464764 10 C METOCLOPRAMIDE. METOCLOPRAMIDE 1 Oral 10 MILLIGRAM DAILY; 0 10 MG TABLET
124647643 12464764 11 C METOCLOPRAMIDE. METOCLOPRAMIDE 1 Oral 10 MILLIGRAM DAILY; 0 10 MG TABLET
124647643 12464764 12 C RAMIPRIL. RAMIPRIL 1 Oral 5 MILLIGRAM DAILY; 0 5 MG TABLET QD
124647643 12464764 13 C RANITIDINE. RANITIDINE 1 Oral 300 MILLIGRAM DAILY; 1200 MG 0 150 MG TABLET BID
124647643 12464764 14 C ZOLEDRONIC ACID ZOLEDRONIC ACID 1 Intravenous (not otherwise specified) .13333333 MG 0 4 MG POWDER /month

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
124647643 12464764 1 Plasma cell myeloma
124647643 12464764 2 Plasma cell myeloma
124647643 12464764 3 Plasma cell myeloma
124647643 12464764 4 Antiviral prophylaxis
124647643 12464764 5 Prophylaxis
124647643 12464764 6 Hypertension
124647643 12464764 7 Pain
124647643 12464764 8 Hypertension
124647643 12464764 9 Diarrhoea
124647643 12464764 10 Prophylaxis of nausea and vomiting
124647643 12464764 11 Prophylaxis of nausea and vomiting
124647643 12464764 12 Hypertension
124647643 12464764 13 Prophylaxis
124647643 12464764 14 Prophylaxis

Outcome of event

Event ID CASEID OUTC COD
124647643 12464764 HO
124647643 12464764 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
124647643 12464764 Diarrhoea
124647643 12464764 Eye infection
124647643 12464764 Herpes zoster
124647643 12464764 Neutrophil count decreased

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
124647643 12464764 1 20160318 20160321 0
124647643 12464764 2 20160318 20160321 0
124647643 12464764 3 20160318 20160328 0
124647643 12464764 4 20160318 20160407 0
124647643 12464764 5 20160318 20160428 0
124647643 12464764 9 20160322 20160324 0
124647643 12464764 10 20160318 0
124647643 12464764 11 20160318 0
124647643 12464764 13 20160318 0
124647643 12464764 14 20160321 0